Clinical trial
Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
NCT00004083 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00004083 |
|---|---|
| Title | Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer |
| Official title | A Phase II Pilot Study of SPI-77 (Stealth Liposomal Cisplatin) in Patients With Recurrent Platinum-Sensitive Ovarian Cancer |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | cisplatin liposomal |
| Start date | Feb 1, 1999 |
| Primary completion | Dec 1, 1999 |
| First posted | Sep 14, 2004 |
| Last update posted | Mar 28, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: